1. Home
  2. SEMR vs NUVB Comparison

SEMR vs NUVB Comparison

Compare SEMR & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEMR
  • NUVB
  • Stock Information
  • Founded
  • SEMR 2008
  • NUVB 2018
  • Country
  • SEMR United States
  • NUVB United States
  • Employees
  • SEMR N/A
  • NUVB N/A
  • Industry
  • SEMR EDP Services
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEMR Technology
  • NUVB Health Care
  • Exchange
  • SEMR Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • SEMR 1.1B
  • NUVB 1.1B
  • IPO Year
  • SEMR 2021
  • NUVB N/A
  • Fundamental
  • Price
  • SEMR $7.35
  • NUVB $3.63
  • Analyst Decision
  • SEMR Buy
  • NUVB Strong Buy
  • Analyst Count
  • SEMR 6
  • NUVB 7
  • Target Price
  • SEMR $13.50
  • NUVB $8.43
  • AVG Volume (30 Days)
  • SEMR 1.2M
  • NUVB 6.7M
  • Earning Date
  • SEMR 11-05-2025
  • NUVB 11-05-2025
  • Dividend Yield
  • SEMR N/A
  • NUVB N/A
  • EPS Growth
  • SEMR N/A
  • NUVB N/A
  • EPS
  • SEMR N/A
  • NUVB N/A
  • Revenue
  • SEMR $413,962,000.00
  • NUVB $14,355,000.00
  • Revenue This Year
  • SEMR $20.28
  • NUVB $291.13
  • Revenue Next Year
  • SEMR $16.41
  • NUVB $332.00
  • P/E Ratio
  • SEMR N/A
  • NUVB N/A
  • Revenue Growth
  • SEMR 22.16
  • NUVB 900.35
  • 52 Week Low
  • SEMR $6.91
  • NUVB $1.54
  • 52 Week High
  • SEMR $18.74
  • NUVB $4.09
  • Technical
  • Relative Strength Index (RSI)
  • SEMR 48.88
  • NUVB 56.11
  • Support Level
  • SEMR $6.91
  • NUVB $3.50
  • Resistance Level
  • SEMR $7.45
  • NUVB $3.88
  • Average True Range (ATR)
  • SEMR 0.31
  • NUVB 0.25
  • MACD
  • SEMR 0.02
  • NUVB -0.02
  • Stochastic Oscillator
  • SEMR 55.00
  • NUVB 59.37

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: